Ventures Associate Director – Therapeutics

Schrodinger seeks a Ventures Associate Director - Therapeutics to join us in our mission to transform the discovery of therapeutics and materials.

Schrodinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Our multidisciplinary drug discovery team also leverages the software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

As a member of our Therapeutics Group, you will leverage your deep research background in immunology, autoimmune biology, and inflammation, as well as your venture experience, to source, evaluate, and incubate the next generation of therapeutic hypotheses and transformative biotech opportunities. This is a corporate venture role sourcing and diligencing early-stage biotech opportunities for Schrodinger's venture creation efforts.

Who Will Love This Job

A scientific investor who enjoys bridging the gap between breakthrough science and commercial venture creation. A researcher with a successful track record of high-impact, peer-reviewed publications and deep expertise in immune pathways, inflammatory cascades, and/or mechanisms of inflammaging. A skilled synthesizer of complex biological literature who can ask incisive questions and spot critical flaws or hidden potential in early-stage data. A business strategist who understands early-stage biotech financing, valuation drivers, IP strategy, and drug development lifecycles.

What You'll Do

Perform rigorous, hypothesis-driven scientific diligence on the landscape of early-stage mechanisms and stealth startups in immunology, autoimmune diseases, chronic inflammation, and age-related immune dysfunction. Critically evaluate preclinical data packages, mechanism-of-action validity, therapeutic differentiation, target tractability, and intellectual property landscapes. Engage with key opinion leaders, academic principal investigators, and clinical experts to validate scientific theses and therapeutic feasibility. Track and map emerging paradigms across academic research institutions, tech transfer offices, and clinical advancements in immunology and inflammation. Source high-quality deal flow by building relationships across the biotech venture ecosystem.